Tempus Integrated Molecular Evaluation (TIME) Trial
Jun 04, 2019
During this week's American Society of Clinical Oncology meeting, Tempus introduced Tempus Integrated Molecular Evaluation (TIME) Trial. This service features a proprietary technology platform that analyzes molecular and clinical data on cancer patients in real time to match people to clinical trials. TIME Trial only sends patients to prequalified academic and community cancer centers so those who qualify can enroll right away.